Drug comparisons
Tirzepatide vs Pioglitazone
Compare Tirzepatide (Mounjaro) vs Pioglitazone (Actos) for T2 diabetes. Dual GIP/GLP-1 agonist vs TZD: A1C, weight loss vs gain, CV risks, warnings.
No comparison dimensions are available for this page.
Clinical context
Type 2 diabetes patients comparing injectable dual incretin agonist tirzepatide against oral TZD pioglitazone for control, weight, and heart risks.
Bottom line
Tirzepatide typically outperforms pioglitazone in A1C and weight loss for T2D but is injectable with GI effects.
All medication comparisons